ArticleFrontiers in oncology2023

A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.

Howard Fine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.